Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

MAIA Biotechnology, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               
Security
Type		  

Security

Class

Title

   Fee
Calculation
Rule		   Amount
Registered(1)		  

Proposed
Maximum
Offering

Price Per
Unit

  

Maximum
Aggregate
Offering

Price

  

Fee

Rate

  

Amount of
Registration

Fee

               
Equity   Common Stock, $0.0001 par value per share   Other(3)   3,838,668(2)   $2.105(3)   $8,080,396.14   $0.0001476   $1,192.67
         
Total Offering Amount     $8,080,396.14     $1,192.67
         
Total Fees Previously Paid         — 
         
Total Fee Offsets         — 
         
Net Fee Due               $1,192.67

 

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover an indeterminate number of additional shares of common stock, $0.0001 par value per share (the “Common Stock”) of MAIA Biotechnology, Inc. (the “Registrant”), which become issuable under the 2021 Plan (as defined below) by reason of any stock splits, stock dividends, reorganizations, mergers, consolidations, recapitalizations or other similar transactions.

(2)

Represents 2,838,668 shares of Common Stock that were automatically added to the shares authorized for issuance under the 2021 Equity Incentive Plan, as amended (the “2021 Plan”) on January 1, 2024 pursuant to an “evergreen” provision contained in the 2021 Plan. On May 25, 2023, the stockholders of the Registrant approved an amendment to the 2021 Plan to include an automatic increase in the aggregate number of shares reserved for awards under the 2021 Plan, commencing on the date of stockholder approval of the amendment, and then each January 1 following thereafter, and ending on (and including) January 1, 2032 (each an “Increase Date”), in an amount equal to ten (10%) of the total number of shares of Common Stock on a fully diluted basis outstanding on December 31 of the preceding calendar year; provided that, the board of directors of the Registrant may act prior to any Increase Date to provide that there will be no increase for such year or that the increase for such year will be a lesser number of shares than provided in the 2021 Plan. In addition, the Company is registering an additional 1,000,000 share in respect of shares issued under the 2021 Plan that are forfeit or expire are available for future grants of awards under the 2021 Plan.

(3)

Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act, based on the average of the high and low sales prices of the Common Stock as reported on NYSE American on April 15, 2024, which was $2.105 per share.